{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:07:03Z","timestamp":1788671223059,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40121-022-00689-7","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T06:02:39Z","timestamp":1667368959000},"page":"2265-2277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase\u00a0III Clinical Trials"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-7326","authenticated-orcid":false,"given":"Sean","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-2393","authenticated-orcid":false,"given":"C\u00e9line","family":"Boutry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-6283","authenticated-orcid":false,"given":"Nicolas","family":"Lecrenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-5667","authenticated-orcid":false,"given":"Anthony L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-2155","authenticated-orcid":false,"given":"Kenneth","family":"Schmader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"1","key":"689_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1741-7015-8-37","volume":"8","author":"RW Johnson","year":"2010","unstructured":"Johnson RW, Bouhassira D, Kassianos G, Lepl\u00e8ge A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8(1):37.","journal-title":"BMC Med"},{"issue":"5","key":"689_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"JW Gnann","year":"2002","unstructured":"Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med. 2002;347(5):340\u20136.","journal-title":"N Engl J Med"},{"issue":"3","key":"689_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI. Herpes zoster. N Engl J Med. 2013;369(3):255\u201363.","journal-title":"N Engl J Med"},{"issue":"5","key":"689_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2165\/00128071-200506050-00005","volume":"6","author":"A Volpi","year":"2005","unstructured":"Volpi A, Gross G, Hercogova J, Johnson RW. Current management of herpes zoster. Am J Clin Dermatol. 2005;6(5):317\u201325.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"689_CR5","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez I, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(5):1\u201330.","journal-title":"MMWR Recomm Rep"},{"issue":"RR-5","key":"689_CR6","first-page":"1","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","unstructured":"Centers for Disease Control and Prevention. Prevention of zoster. MMWR Recomm Rep. 2008;57(RR-5):1\u201330.","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"689_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6): e004833.","journal-title":"BMJ Open"},{"issue":"16","key":"689_CR8","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson RW, Rice ASC. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526\u201333.","journal-title":"N Engl J Med"},{"issue":"9","key":"689_CR9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","volume":"62","author":"BF Jung","year":"2004","unstructured":"Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62(9):1545.","journal-title":"Neurology"},{"issue":"4","key":"689_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10389-011-0481-8","volume":"20","author":"K Lukas","year":"2012","unstructured":"Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. J Public Health. 2012;20(4):441\u201351.","journal-title":"J Public Health"},{"issue":"6","key":"689_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","volume":"5","author":"PM Coplan","year":"2004","unstructured":"Coplan PM, Schmader K, Nikas A, et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain. 2004;5(6):344\u201356.","journal-title":"J Pain"},{"issue":"1","key":"689_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2334-14-402","volume":"14","author":"A Gater","year":"2014","unstructured":"Gater A, Abetz-Webb L, Carroll S, Mannan A, Serpell M, Johnson R. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis. 2014;14(1):402.","journal-title":"BMC Infect Dis"},{"key":"689_CR13","first-page":"341","volume-title":"VZV T cell-mediated immunity. Current topics in microbiology and immunology","author":"A Weinberg","year":"2010","unstructured":"Weinberg A, Levin MJ. VZV T cell-mediated immunity. Current topics in microbiology and immunology. Berlin: Springer; 2010. p. 341\u201357."},{"issue":"1","key":"689_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44(1):S1\u201326.","journal-title":"Clin Infect Dis"},{"issue":"22","key":"689_CR15","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087\u201396.","journal-title":"N Engl J Med"},{"issue":"11","key":"689_CR16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70\u00a0years of age or older. N Engl J Med. 2016;375(11):1019\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"689_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2019.9053","volume":"322","author":"A Bastidas","year":"2019","unstructured":"Bastidas A, de la Serna J, El Idrissi M, et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA. 2019;322(2):123\u201333.","journal-title":"JAMA"},{"issue":"8","key":"689_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/gerona\/gly150","volume":"74","author":"D Curran","year":"2019","unstructured":"Curran D, Oostvogels L, Heineman T, et al. Quality of life impact of an adjuvanted recombinant zoster vaccine in adults aged 50\u00a0years and older. J Gerontol. 2019;74(8):1231\u20138.","journal-title":"J Gerontol"},{"issue":"12","key":"689_CR19","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/j.bbmt.2019.07.036","volume":"25","author":"D Curran","year":"2019","unstructured":"Curran D, Matthews S, Rowley SD, et al. Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT). Biol Blood Marrow Transpl. 2019;25(12):2474\u201381.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"689_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020528","volume":"8","author":"EA Yanni","year":"2018","unstructured":"Yanni EA, Ferreira G, Guennec M, et al. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000\u20132012. BMJ Open. 2018;8(6): e020528.","journal-title":"BMJ Open"},{"key":"689_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2911","volume":"348","author":"HJ Forbes","year":"2014","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014;348: g2911.","journal-title":"BMJ"},{"issue":"9","key":"689_CR22","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/art.39670","volume":"68","author":"H Yun","year":"2016","unstructured":"Yun H, Yang S, Chen L, et al. Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination. Arthritis Rheumatol. 2016;68(9):2328\u201337.","journal-title":"Arthritis Rheumatol"},{"key":"689_CR23","first-page":"D4825","volume":"164","author":"SLL Wanders","year":"2020","unstructured":"Wanders SLL, Miriam AM, Baak M. Risk factors for disseminated herpes zoster. Ned Tijdschr Geneeskd. 2020;164:D4825.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"689_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40121-021-00581-w","volume":"11","author":"D Van Oorschot","year":"2022","unstructured":"Van Oorschot D, McGirr A, Goulet P, et al. A cross-sectional concept elicitation study to understand the impact of herpes zoster on patients\u2019 health-related quality of life. Infect Dis Therapy. 2022;11(1):501\u201316.","journal-title":"Infect Dis Therapy"},{"issue":"5","key":"689_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/ICL.0000000000000591","volume":"45","author":"AR Davis","year":"2019","unstructured":"Davis AR, Sheppard J. Herpes zoster ophthalmicus review and prevention. Eye Contact Lens. 2019;45(5):286\u201391.","journal-title":"Eye Contact Lens"},{"issue":"178","key":"689_CR26","first-page":"2398","volume":"4","author":"PO Lang","year":"2008","unstructured":"Lang PO, Martin Z-L, Pautex S. Herpes zoster and post-herpetic neuralgia in older adults. Rev Med Suisse. 2008;4(178):2398\u2013404.","journal-title":"Rev Med Suisse"},{"issue":"10","key":"689_CR27","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1086\/320157","volume":"32","author":"M Offidani","year":"2001","unstructured":"Offidani M, Corvatta L, Olivieri A, et al. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation. Clin Infect Dis. 2001;32(10):1414\u201322.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"689_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1399-3062.2011.00655.x","volume":"13","author":"JE Rogers","year":"2011","unstructured":"Rogers JE, Cumpston A, Newton M, Craig M. Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population. Transpl Infect Dis. 2011;13(5):480\u20134.","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"689_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/AJP.0b013e3181eef686","volume":"26","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Levin MJ, et al. A prospective study of the herpes zoster severity of illness. Clin J Pain. 2010;26(8):656\u201366.","journal-title":"Clin J Pain"},{"issue":"3","key":"689_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","volume":"67","author":"KL Dooling","year":"2018","unstructured":"Dooling KL, Guo A, Patel M, et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. Morb Mortal Wkly Rep. 2018;67(3):103\u20138.","journal-title":"Morb Mortal Wkly Rep"},{"key":"689_CR31","unstructured":"Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP). 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/recommendations.html. Accessed 10 Oct 2022."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00689-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00689-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00689-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T10:23:19Z","timestamp":1668594199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00689-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00689-7","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}